The expression of human leukocyte function-associated antigens (HLFA, equivalents of murine LFA-1) was studied on early lympho-hemopoietic cells in infant thymus and normal bone marrow by double immunofluorescence methods, cell sorting and colony-forming assays. Monoclonal antibodies MHM-24 recognizing the alpha chain (180 kDa) and 60.3 and 60.1 identifying the beta chain (95 kDa) were used. The vast majority of thymocytes including large terminal deoxynucleotidyl transferase (TdT)-positive blast cells are HLFA positive. On the other hand, most B cell precursors in the bone marrow, identified by the expression of nuclear TdT, do not show surface HLFA which appears at the pre-B cell stage (cytoplasmic mu positive, surface Ig negative). Cell sorting experiments revealed an enrichment of early myeloid cells (myeloblasts and colony-forming unit cells) in the HLFA-negative fraction. Erythroid cells appeared to be completely negative from the burst-forming unit erythrocyte stage onwards. Anti-HLFA-antibodies, capable of blocking T cell and natural killer function, may have therapeutic potential without interfering with precursor cell development in man.
No takes yet. Share an insight, caveat, or question.
Campana et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: